Viracta Receivables Turnover from 2010 to 2024

VIRX Stock  USD 0.25  0.02  8.70%   
Viracta Therapeutics Receivables Turnover yearly trend continues to be fairly stable with very little volatility. Receivables Turnover will likely drop to 50.35 in 2024. During the period from 2010 to 2024, Viracta Therapeutics Receivables Turnover regression line of annual values had r-squared of  0.32 and arithmetic mean of  61.68. View All Fundamentals
 
Receivables Turnover  
First Reported
2010-12-31
Previous Quarter
56.65
Current Value
50.35
Quarterly Volatility
3.52945741
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Viracta Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viracta Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 324.1 K, Interest Expense of 3.9 M or Selling General Administrative of 13.7 M, as well as many indicators such as Price To Sales Ratio of 5.9, Dividend Yield of 0.0 or PTB Ratio of 1.14. Viracta financial statements analysis is a perfect complement when working with Viracta Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Viracta Therapeutics Correlation against competitors.
For more information on how to buy Viracta Stock please use our How to Invest in Viracta Therapeutics guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Viracta Stock Analysis

When running Viracta Therapeutics' price analysis, check to measure Viracta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viracta Therapeutics is operating at the current time. Most of Viracta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viracta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viracta Therapeutics' price. Additionally, you may evaluate how the addition of Viracta Therapeutics to your portfolios can decrease your overall portfolio volatility.